July 13, 2026 a 04:38 pm

BDX: Analysts Ratings - Becton, Dickinson and Company

Historical Stock Grades

Recent analyst ratings for Becton, Dickinson and Company reveal a stable and cautious stance among analysts. The data from July 2026 demonstrate a consistent pattern of 'Buy' and 'Hold' recommendations, suggesting confidence in the company's operations but urging vigilance amid industry volatility.

Recommendation	Count	Score
Strong Buy	0
Buy	6
Hold	8
Sell	0
Strong Sell	0

Sentiment Development

The sentiment analysis over recent months for BDX displays a sustained 'Hold' sentiment, while 'Strong Buy' ratings have diminished. This suggests a shift towards a more conservative stance among analysts and reflects potential caution in investor behavior.

• Notable increase in 'Hold' ratings from April 2026 onwards.
• 'Strong Buy' ratings have ceased post-May 2026, indicating reduced aggressive bullishness.
• Overall, the total number of ratings has shown fluctuations but remains dominantly positive.

Percentage Trends

The percentage analysis indicates a noteworthy transition from bullish to cautious stances among analysts. This shift is reflected in the diminishing 'Strong Buy' recommendations and a steady 'Hold' position.

• From July 2025 to July 2026, 'Hold' recommendations increased by approximately 25%.
• 'Buy' recommendations remained relatively constant, sustaining confidence but with caution.
• There is a clear decline in the 'Strong Buy' category, dropping to zero in recent observations.

Latest Analyst Recommendations

Recent analyst recommendations for BDX have largely maintained their previous ratings, reflecting stability in the company’s perceived market position.

Date	New Recommendation	Last Recommendation	Publisher
2026-07-06	Outperform	Outperform	Evercore ISI Group
2026-05-11	Overweight	Overweight	Barclays
2026-05-08	Equal Weight	Equal Weight	Wells Fargo
2026-05-04	Hold	Hold	TD Cowen
2026-04-17	Neutral	Neutral	Piper Sandler

Analyst Recommendations with Change of Opinion

Analysis of recent changes in analyst recommendations highlights notable downgrades, suggesting a re-evaluation of BDX’s market outlook by some perspectives.

Date	New Recommendation	Last Recommendation	Publisher
2025-05-22	Neutral	Buy	Citigroup
2025-05-02	Neutral	Overweight	Piper Sandler
2025-05-01	Market Perform	Outperform	William Blair
2024-10-01	Buy	Neutral	Citigroup
2023-07-24	Outperform	Market Perform	Raymond James

Interpretation

The current analysis of BDX indicates a balanced but cautious market estimation. Analysts seem to be adopting a wait-and-see approach, influenced by external economic factors and internal performance metrics. There is minimal evidence of growing confidence, with opinions largely unchanged or downgraded, signifying potential uncertainty. Stability in recommendations, however, points to consistent foundational strengths of BDX's business model and market presence.

Conclusion

In conclusion, Becton, Dickinson and Company shows a resilient market presence, with its dynamic product offerings maintaining analyst interest and cautious optimism. The recent decline in 'Strong Buy' recommendations and a proportional increase in 'Hold' ratings reflect strategic patience encouraged by analysts amid market conditions. A stable operational approach and comprehensive product portfolio position BDX as a reliable, albeit conservative, investment opportunity, providing a shield against significant market fluctuations. Investors are advised to weigh the potential for long-term growth against the backdrop of broader economic volatilities impacting the healthcare technology sector.